艾德生物: 监事会决议公告

Group 1 - The fourth supervisory board meeting of Xiamen Aide Biological Pharmaceutical Technology Co., Ltd. was held on July 28, 2025, with all three supervisors present, meeting the legal requirements [1][2] - The supervisory board approved the company's 2025 semi-annual report, confirming that the report's preparation and review processes comply with relevant laws and regulations, and accurately reflect the company's actual situation without any false statements or omissions [1][2] - The supervisory board also reviewed and approved adjustments to the 2023 restricted stock incentive plan, stating that the adjustments do not affect the implementation of the plan and do not harm the interests of shareholders [2]